Shilpa Medicare shares rally over 5% after DRDO approves manufacture, sale of anti-Covid drug

Share of Shilpa Medicare rallied over five percent after the company received in-principle approval from the Defence Research & Development Organisation (DRDO) to manufacture and sale of 2-Deoxy-D-Glucose (2DG). The Drug Controller General of India (DCGI) had granted emergency approval to 2DG for COVID-19 patients…

From vaccines to key drugs, here are key decisions taken during GST Council meeting

These GST rate reductions shall remain in force till September 30, 2021. The Goods and Services Tax Council, under the chairmanship of Union Finance Minister Nirmala Sitharaman, Saturday decided to reduce the GST rates on certain items being used in Covid-19 relief and management till September 30, 2021.…